Startups targeting women’s healthcare have raised $1.1 billion in venture financing since 2014, CB Insights reports.
Prelude, a fertility solutions startup, has raised $200 million and Progyny, backed by Kleiner Perkins, has raised $49 million for its egg-freezing and fertility services. Reproductive therapeutics company ObsEva, based in Geneva, filed for an IPO.
The global femtech market includes Dayima, a Beijing-based menstrual health app maker, which raised $70 million in 2015.
Photo: CB Insights